Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Health Catalyst, Inc - Common stock (HCAT)
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. “For the full year 2024, I am pleased to share that we achieved strong performance across our business, including total revenue of $307 million and Adjusted EBITDA of $26 million. Additionally, I am encouraged with our Technology segment, which had revenue of $195 million for full-year 2024 and $52 million for the fourth quarter of 2024, which represents 10% growth year-over-year. I am pleased with this progress and excited that we anticipate a continued reacceleration of topline growth for full year 2025, with our Tech segment growing faster than the total business. Likewise, I am pleased with our profitability progress and excited that we have raised our target for 2025 Adjusted EBITDA by $2 million,
Show less
Read more
Impact Snapshot
Event Time:
HCAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCAT alerts
High impacting Health Catalyst, Inc - Common stock news events
Weekly update
A roundup of the hottest topics
HCAT
News
- Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of DirectorsPR Newswire
- Health Catalyst to Participate in Upcoming Investor ConferencesGlobeNewswire
- Health Catalyst Inc (HCAT) Q3 2025 Earnings Call Highlights: Strong Technology Growth Amid ... [Yahoo! Finance]Yahoo! Finance
- Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.50 to $3.25. They now have a "neutral" rating on the stock.MarketBeat
- Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Stifel Nicolaus from $4.50 to $3.75. They now have a "hold" rating on the stock.MarketBeat
HCAT
Earnings
- 11/10/25 - Beat
HCAT
Sec Filings
- 12/9/25 - Form 4
- 12/9/25 - Form 4
- 12/5/25 - Form 144
- HCAT's page on the SEC website